Eu Ppe Regulation Testing Services
PPE testing under Regulation (EU) 2016/425 is an evidence-design task, not a generic order for a ‘CE test’. Before sending samples, define the hazard, intended protection, product variants and the evidence each applicable essential health and safety requirement needs. A successful test report alone is not an EU type-examination certificate.
This guide is for manufacturers and importers commissioning EU PPE Regulation testing services. It focuses on test selection, laboratory and notified-body competence, samples, previous reports, failed tests and design changes—not the full certification project.
1. Fix the testing route before requesting quotations
Scope gate: first confirm that Article 2 covers the product. For example, PPE designed for private use against ordinary (non-extreme) weather, and motorcycle helmets or visors covered by UN ECE Regulation No 22, are outside this Regulation. Professional or sports protective equipment is not excluded merely because it resembles an ordinary consumer product. Do not assign a PPE category before checking intended use and applicable exclusions.
Annex I classifies PPE by the risks protected against. Under Article 19, category I uses module A (manufacturer's internal production control); category II uses module B EU type-examination followed by module C; category III uses module B plus module C2 or D. A narrow exception applies to category III PPE made as a single unit for an individual user. Category I still requires evidence of compliance; it does not require a notified-body type-examination. Do not let a testing provider assign the category solely from a product name.
| Risk route | Assessment evidence needed | Do not confuse |
|---|---|---|
| Category I | Module A; technical file with evidence; no mandatory module B | A lab report is not the manufacturer’s compliance decision |
| Category II | Module B: type examination by notified body; then module C | A testing quotation is not the type certificate |
| Category III | Module B plus C2 (supervised product checks) or D (production QA) | Initial type testing does not replace ongoing control |
2. Build an evidence-to-test matrix, not a standards shopping list
Start from the hazard assessment and Annex II essential health and safety requirements. Map each claimed protection level to appropriate tests, inspection or engineering justification, sample variants and pass criteria. Harmonised standards are one means of demonstrating conformity: presumption under Article 14 applies only to requirements covered by standards whose references are published in the Official Journal, including any restrictions. Where standards are not used or are used partly, document the alternative technical specifications and supporting rationale.
As of October 2026, check Commission Implementing Decision (EU) 2026/1279, as amended by (EU) 2026/1971, including deferred withdrawal dates. Decision 2023/941 was repealed subject to transitional references. Never assume that an old standard number in a supplier report remains the appropriate current basis.
Concrete October 2026 example: Decision (EU) 2026/1971 postpones withdrawal of the OJ references to EN 12941:1998 and EN 12942:1998 (with the amendments listed in that decision) until 8 October 2027. This concerns the period of presumption of conformity for covered requirements; it does not automatically validate an old test report or avoid examination of the current product.
| Before booking, resolve | Proof / input | Written answer needed from provider |
|---|---|---|
| Claim and hazard | Intended use, limits and risk assessment | Which Annex II requirements and performance properties are in scope? |
| Standard edition | OJ citation, restrictions, withdrawals and alternatives | Which clauses/tests and methods apply on the assessment date? |
| Variants and sizes | Drawings, materials, BOM and protection options | Which samples represent which variants, and why? |
| Sample logistics | Production revision, quantities, conditioning, traceability | How many units, who selects them, and which tests are destructive? |
| Existing data | Original reports, laboratory scope and deviation history | What can be relied on; what gaps require fresh evidence? |
3. Confirm laboratory competence and the notified-body interface
For module B, only a body notified under Regulation (EU) 2016/425 for the relevant activities can issue the EU type-examination certificate. Confirm the precise legal entity, four-digit notified-body number, NANDO scope, product/assessment competence and who will sign the decision. A laboratory's ISO/IEC 17025 accreditation is useful evidence of specified testing competence, but is not itself a PPE notification or an approval of the product.
Identify the legal applicant before booking module B testing. Under Annex V, the manufacturer applies for EU type-examination, or an authorised representative may apply where its mandate covers that act. Paying for tests does not by itself make an importer the applicant. Under Article 12, an importer or distributor placing PPE on the market under its own name or trademark, or modifying PPE so that conformity may be affected, assumes manufacturer obligations. Record the applicant, intended certificate holder and rights to obtain and share reports.
Ask whether the notified body will conduct or commission each test, whether it will accept testing done by another laboratory, and which records and sample traceability it requires. Under Annex V the notified body examines the design, checks specimens and performs or has appropriate tests performed; it retains the certification decision. A voluntary certificate cannot replace legally required module B.
4. Freeze samples and represent the commercial product
Annex V requires specimen(s) representative of intended production and permits the notified body to request more. Before dispatch, agree variant coverage for sizes, materials, coatings, filters, closures and protective options; worst-case grouping must be justified, not asserted. Record part numbers, manufacturing site, production lot, sample condition, photographs, drawing revision and chain of custody.
Separate development prototypes from production-representative specimens. Ask which tests destroy or condition samples, which need unused duplicates, and whether the body must witness or select specimens. Made-to-measure series and individually fitted products have special sample/model provisions in Annex V; do not assume a single convenient size proves the whole range.
5. Decide whether an existing report can actually be reused
A prior EN, ISO or overseas test report may help reduce duplicate measurement, but there is no automatic EU-wide rule that forces a notified body to adopt it. Evaluate: exact model and construction; test-method edition and deviations; covered hazards and performance class; accreditation scope at test date; original results and uncertainty where material; sample identity; report integrity; and any later design or standard changes.
Request a written gap/acceptance decision from the prospective notified body before spending money on additional tests. A report from a non-notified laboratory can be supporting evidence; it does not by itself replace the EU type-examination decision for categories II and III.
6. Manage failure, retesting and product changes
Treat a failure as evidence of a specific design, production or claim deficiency. Quarantine the affected design revision, obtain raw results and failure mode, correct the product or narrow an unsupported claim, then define whether the affected tests and their dependent tests need repeating. Never relabel a failed unit as a pass by changing a marketing statement without reassessing intended use and requirements.
For an approved type, Annex V point 7.2 requires reporting modifications that may affect conformity or certificate validity to the notified body and additional approval. Material, geometry and critical suppliers can change protective performance; marking/instructions can affect compliance even when measured performance stays similar. Changes in state of the art and standard references require review, but do not automatically imply every test must be repeated. The body determines the necessary examinations; a simplified certificate review exists in the conditions of Annex V point 7.6.
Do not treat the simplified review in Annex V, point 7.6, as a shortcut after a product change: it concerns renewal where the notified body confirms that no relevant change to the approved type, applied specifications or state of the art has occurred. A modification requiring additional approval remains subject to point 7.2.
| Trigger | Risk to evidence | Practical decision before release |
|---|---|---|
| Material / coating / filter change | Protection, durability or chemical performance can shift | Run impact analysis; agree affected retests with body |
| Fit, shape or size-range change | Coverage, retention, seal or ergonomics may change | Recheck variant/worst-case logic and relevant tests |
| New factory or critical process | Production equivalence and consistency may change | Verify controls and category III surveillance implications |
| Label, instruction or claim change | Documentary compliance and intended-risk scope may change | Review Annex II information and testing claims |
| New standard reference or state of art | Old evidence may no longer cover all requirements | Check current OJ; request body review, not automatic blanket retest |
7. Purchase the right testing deliverables
Specify a deliverable bundle: approved test plan and standard editions, test-by-test quotation, sample quantities and conditioning, raw findings and signed reports, failures/nonconformities, report ownership and permission to share with the notified body, retention arrangements, retest pricing, and change-notification procedure. Ensure every report ties the measured result to a traceable sample, performance claim and technical file version.
Category III production surveillance must not be confused with initial type testing: module C2 provides notified-body product checks at random intervals at least annually; module D uses approved production quality assurance with periodic audits at least annually. These are different evidence streams from pre-market design testing.
8. Next action: a seven-question laboratory brief
Send a one-page brief with the intended protective use and hazards, provisional Annex I risk category, model/variant list, bill of materials and drawings, protection claims and target markets, current test reports and deviations, intended standard editions checked against the current OJ, and requested launch/design-freeze timing. The first response should identify unresolved tests and the competent decision-maker—not merely a total price.
- Which Annex II requirements and protection claims will each proposed test substantiate, and which requirements remain uncovered?
- Which standard editions, clauses, OJ references, restrictions and withdrawal dates are you using, and what alternative specifications are proposed?
- Which legal entity will perform the tests, what is its relevant competence/accreditation scope, and which PPE-notified body will make the module B decision, if applicable?
- Which production-representative models, sizes, materials and worst-case variants are required; how many samples, and which tests are destructive?
- Will the responsible notified body review our existing reports before commissioning more tests, and what written evidence gaps does it identify?
- What is the procedure and quotation for nonconformities, corrective changes, affected retests and any additional type approval?
- Which traceable signed reports, data, sample identifiers, deviations, sharing permissions and delivery stages are included in the quote?
FAQ: PPE test commissioning
Can I order tests before selecting a notified body?
Yes, as development work, but for categories II/III first obtain the intended notified body’s written position on methods, samples and external reports to reduce wasted testing.
Does ISO/IEC 17025 accreditation make a laboratory an EU PPE notified body?
No. Accreditation describes competence for its stated scope; notification and scope for Regulation (EU) 2016/425 are verified separately through NANDO.
Will my old EN-standard report be accepted after the 2026 standards update?
Not automatically. Check the specific OJ reference, restrictions and withdrawal date, the tested edition, unchanged product identity and the notified body’s gap assessment.
Must every colour and size be destructively tested?
Not necessarily. Sampling depends on protection-critical differences and the applicable test programme; the notified body may demand further specimens. Document the coverage rationale.
Does a failed test or a material substitution require all tests again?
No universal rule mandates blanket retesting. Diagnose the failure or change, assess all affected requirements and obtain the relevant notified-body decision where module B applies.
Official sources and adjacent services
- PPE Regulation 2016/425
- PPE standards decision 2026/1279
- Amending decision 2026/1971
- Commission PPE guidance / NANDO
- Commission PPE harmonised standards
Practical boundary: this page addresses test evidence and commissioning. For the complete conformity-assessment execution, see the linked certification service; for classification and gap strategy, see consulting. EU PPE certification workflow; PPE compliance consulting.